Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects. - Wikidata - wikimedia - TriplyDB

Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects.

Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects.

http://www.wikidata.org/entity/Q34542239

about

Immunomodulatory Activities of a Fungal Protein Extracted from Hericium erinaceus through Regulating the Gut Microbiota.Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy.Gut microbiota modulation of chemotherapy efficacy and toxicity.Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation.Homeostatic Immunity and the Microbiota.Deciphering interactions between the gut microbiota and the immune system via microbial cultivation and minimal microbiomes.Anticancer effects of the microbiome and its products.Microbiota: a key orchestrator of cancer therapy.The role of the microbiome in cancer development and therapy.Pathogenic Role of IL-17-Producing Immune Cells in Obesity, and Related Inflammatory Diseases.[Gut microbiota and efficacy of cancer therapies].Fecal microbiota of lambs fed purple prairie clover (Dalea purpurea Vent.) and alfalfa (Medicago sativa).Microbiota-gut-brain axis and the central nervous system.Moderate-Intensity Exercise Affects Gut Microbiome Composition and Influences Cardiac Function in Myocardial Infarction Mice.Targeting myeloid derived suppressor cells with all-trans retinoic acid is highly time-dependent in therapeutic tumor vaccination.Desired Turbulence? Gut-Lung Axis, Immunity, and Lung Cancer Association of Immunotherapy With Overall Survival in Elderly Patients With Melanoma.The impact of antibiotic usage on the efficacy of chemoimmunotherapy is contingent on the source of tumor-reactive T cells.T cell modulation by cyclophosphamide for tumour therapy.Putative predictors of efficacy for immune checkpoint inhibitors in non-small-cell lung cancer: facing the complexity of the immune system.Cancer treatment: Bacterial snack attack deactivates a drug.The Complex Interplay between Chronic Inflammation, the Microbiome, and Cancer: Understanding Disease Progression and What We Can Do to Prevent It.Microbiota transplantation: concept, methodology and strategy for its modernization.Probiotic Species in the Modulation of Gut Microbiota: An Overview.Concepts Collide: Genomic, Immune, and Microbial Influences on the Tumor Microenvironment and Response to Cancer Therapy.Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies.Microbial markers in colorectal cancer detection and/or prognosis.The contribution of culturomics to the repertoire of isolated human bacterial and archaeal species.Gut microbiome modulates efficacy of immune checkpoint inhibitors.Diet, Microbiota and Gut-Lung Connection TumGrowth: An open-access web tool for the statistical analysis of tumor growth curves Checkpoint blockade-based immunotherapy in the context of tumor microenvironment: Opportunities and challenges Intestinal microbiota: a novel perspective in colorectal cancer biotherapeutics Grow With the Challenge - Microbial Effects on Epithelial Proliferation, Carcinogenesis, and Cancer Therapy Diosgenin promotes antitumor immunity and PD-1 antibody efficacy against melanoma by regulating intestinal microbiota Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors Gut microbiota, chemotherapy and the host: the influence of the gut microbiota on cancer treatment

P2860

Q33856396-8F0705DB-C7F4-4186-BBB6-F3DD205D842B Q33883909-299440E5-35C0-4C84-8E7E-FDE2D3201DC6 Q36300217-6D9C8A9D-816E-4096-973C-0778A74DD212 Q36308832-3DF94DBE-5CC8-477D-8867-AE32A4B8C1E7 Q36351062-FD5E917E-EF39-463C-B8E2-CE8A7CA0BBB4 Q38600883-0ABCF21A-CE2F-4A02-B60B-70369E9EC37A Q38681126-DF7131C8-0D10-40A1-AE28-528EB8B64015 Q39183428-745CA94E-9E73-446A-A82B-56604A6065F0 Q39290620-4A51D397-01C0-4CED-A451-E838BBF988F5 Q39434888-88C8D3DD-C1D1-4B2A-8ACF-527583A7CACA Q40145678-BA760B81-6267-465A-9614-B0B2FE1D2B4C Q40501666-09752F04-0CF8-40EF-BC84-0C415A2C1B05 Q41593417-92F33C5C-A641-4D57-AD0F-2788BA071DF3 Q41619531-CC661DFE-F762-40D4-B2EC-BB3467AD99F3 Q41935730-D8F5806A-EA72-4821-9D7F-4828F2D603B0 Q42718218-CBF95172-6F6E-42A5-8DA0-16D1459B352D Q47321362-63BA874C-000E-4B6F-8564-390C22EFE893 Q49276632-4C06B111-3072-4F87-8D5A-E44E80B36D9F Q49822317-5FFED3E8-DD17-430D-96D3-AA2A8A1A4CD1 Q50070316-98CBAAA9-319A-49E7-8666-D238558EE193 Q50100893-34FADC09-A277-4437-B582-2D0DDA05850E Q52349005-B80BF424-3BD3-4181-A78B-3146C2C95D20 Q52716963-8F35B2D6-6872-4E39-8B05-555852F7DD1D Q55027051-18B096EC-085C-4CF9-BFAB-37E580E25642 Q55034685-214AD01F-6340-440C-AF94-5F4305E5E33F Q55040688-23AF2634-CF2B-483D-944F-B83DFE2C7340 Q55094334-EE533DE2-DD49-468D-A902-D1F01AE7C3E8 Q55121552-31203E02-3B54-475B-B8A2-A8E88B57018D Q55240704-7B382170-8AB0-4913-8C1F-F64B912759BB Q57072837-206502C8-7951-46FD-B82F-7DF753AE6F2D Q57082682-D65789B9-6FE9-4074-B754-90D64CBC67E3 Q57162847-0A15B9A6-E210-40A0-B580-EF2141715ECD Q57169731-B6F48C94-A1B3-4EB0-9E67-7FB2DAF7FEA2 Q57191774-3577B268-C102-45C9-A36E-D08514A932F6 Q57283081-E8C6B6E3-2B60-4541-8F7B-77320864C25D Q58713932-36ADCF6F-0A28-4DAA-8D5C-D2D03C128D96 Q58762645-F2293EE8-481D-4E22-8FD6-C5B07D046919

P2860

Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects.

http://www.wikidata.org/entity/Q34542239

description

2016 nî lūn-bûn

@nan

2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Enterococcus hirae and Barnesi ...... utic Immunomodulatory Effects.

@ast

Enterococcus hirae and Barnesi ...... utic Immunomodulatory Effects.

@en

Enterococcus hirae and Barnesi ...... utic Immunomodulatory Effects.

@nl

type

label

Enterococcus hirae and Barnesi ...... utic Immunomodulatory Effects.

@ast

Enterococcus hirae and Barnesi ...... utic Immunomodulatory Effects.

@en

Enterococcus hirae and Barnesi ...... utic Immunomodulatory Effects.

@nl

prefLabel

Enterococcus hirae and Barnesi ...... utic Immunomodulatory Effects.

@ast

Enterococcus hirae and Barnesi ...... utic Immunomodulatory Effects.

@en

Enterococcus hirae and Barnesi ...... utic Immunomodulatory Effects.

@nl

P1433

Q34542239-3528D8E1-FF7E-42F4-8A87-F993E029F22F

P1476

Q34542239-4AE7C02E-0B1D-4885-A8FE-2DBE6C8C3B61

P2093

Q34542239-1A371D0E-02D0-4F79-AEF4-CE585FC144EF

Q34542239-2A48185F-C446-4E93-B72B-833ADF3A3082

Q34542239-2DAABE1E-2DD9-47E3-911B-1DCC2E7BD8E6

Q34542239-5CBE93E8-33A2-45C4-80C9-1474178FD9F9

Q34542239-72AD7E9F-17EE-4055-AC00-60B1834F30EE

Q34542239-7A3B7570-3B0B-4DC9-ABFB-E6882EDAC9DB

Q34542239-7F1222D1-060C-49FC-B398-D6FD33D5A27B

Q34542239-89B5D7F2-8D47-48CA-8406-877A0E66CB7C

Q34542239-8CD5BA9F-F84C-4659-97FD-95996A4B57D5

Q34542239-96BFF058-D979-4962-93D3-BFE1D8ACE181

P304

Q34542239-7D289B63-CAD1-40E8-8AB3-FF4C2BFFC856

P31

Q34542239-8B310F32-A3DE-47C3-9799-85F771AAA2A0

P356

Q34542239-BAEB2ABF-CB78-4E4D-9D2B-2B00B4336157

P407

Q34542239-03BA8BC7-734B-495D-84D9-BFFC3D1B1E39

P433

Q34542239-B1E7E942-DA2C-47B4-A5E0-52A7A1039790

P478

Q34542239-6BC1423E-A224-4546-9E9D-238E6D0E4FB8

P50

Q34542239-018E67EB-1409-4FE8-8A80-97414711712B

Q34542239-10411687-1EC8-499C-8CC3-BF8543F1D245

Q34542239-15B3CF06-196F-4369-97DA-C6EDE0828FD8

Q34542239-2B99F335-904D-4B7C-87C9-EC131913B093

Q34542239-3073D924-CA5E-46EC-A22C-32A293D2E0F7

Q34542239-41C5A8DE-1A4D-448D-879A-4AAA9F3C9732

Q34542239-4FE246E5-E1DB-4759-8C79-4440F326A28B

Q34542239-6B5A9646-26B6-45A2-9FF5-B1E0118D322B

Q34542239-7236966A-4CF6-4A91-89CB-3D01E59ED452

Q34542239-72DA601C-03AF-43A7-A037-AC452955016C

P577

Q34542239-A248260F-9112-4DE6-89EC-B7B7EA273AB6

P698

Q34542239-72A1256D-5236-4511-98BE-86B564BCF113

P356

J.IMMUNI.2016.09.009

P1433

P1476

Enterococcus hirae and Barnesi ...... utic Immunomodulatory Effects.

@en

P2093

Antoine Roux

http://www.w3.org/2001/XMLSchema#string

Bertrand Routy

http://www.w3.org/2001/XMLSchema#string

Christophe Isnard

http://www.w3.org/2001/XMLSchema#string

Connie P M Duong

http://www.w3.org/2001/XMLSchema#string

David Enot

http://www.w3.org/2001/XMLSchema#string

Elisabeth Chachaty

http://www.w3.org/2001/XMLSchema#string

Encouse Golden

http://www.w3.org/2001/XMLSchema#string

Ivo Gomperts Boneca

http://www.w3.org/2001/XMLSchema#string

Magdalena Plebanski

http://www.w3.org/2001/XMLSchema#string

Maria Paula Roberti

http://www.w3.org/2001/XMLSchema#string

P304

931-943

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IMMUNI.2016.09.009

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P50

Laurence Zitvogel

Alexander Eggermont

Philip Rosenstiel

Jean-Charles Soria

Sylvie Rusakiewicz

Romain Daillère

Nicolas Jacquelot

Paul-Louis Woerther

P577

2016-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27717798

http://www.w3.org/2001/XMLSchema#string